special limited tender enquiry for supply of siv for haj session 2023 price agreement for supply of siv for haj session 2023 , seasonal influenza vaccine ( quadrivalent ) ( for adults ) specification: as per the who recommendations the quadrivalent vaccines for use in the 2023influenza season ( sh ) contain the following: egg-based vaccines • an a / sydney / 5 / 2021 ( h1n1 ) pdm09-like virus; • an a / darwin / 9 / 2021 ( h3n2 ) -like virus; • a b / austria / 1359417 / 2021 ( b / victoria lineage ) -like virus; and • a b / phuket / 3073 / 2013 ( b / yamagata lineage ) -like virus. whichever strain / s is / are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine ( quadrivalent ) ( for adults ) specification: as per the who recommendations the quadrivalent vaccines for use in the 2023 influenza season ( sh ) contain the following: egg-based vaccines • an a / sydney / 5 / 2021 ( h1n1 ) pdm09-like virus; • an a / darwin / 9 / 2021 ( h3n2 ) -like virus; • a b / austria / 1359417 / 2021 ( b / victoria lineage ) -like virus; and • a b / phuket / 3073 / 2013 ( b / yamagata lineage ) -like virus. whichever strain / s is / are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine ( quadrivalent ) ( for adults ) specification: as per the who recommendations the quadrivalent vaccines for use in the 2023 influenza season ( sh ) contain the following: egg-based vaccines • an a / sydney / 5 / 2021 ( h1n1 ) pdm09-like virus; • an a / darwin / 9 / 2021 ( h3n2 ) -like virus; • a b / austria / 1359417 / 2021 ( b / victoria lineage ) -like virus; and • a b / phuket / 3073 / 2013 ( b / yamagata lineage ) -like virus. whichever strain / s is / are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine ( trivalent ) ( for adults ) specification: as per the who recommendations the trrivalent vaccines for use in the 2023 influenza season ( sh ) contain the following: egg-based vaccines • an a / sydney / 5 / 2021 ( h1n1 ) pdm09-like virus; • an a / darwin / 9 / 2021 ( h3n2 ) -like virus; and • a b / austria / 1359417 / 2021 ( b / victoria lineage ) -like virus. whichever strain / s is / are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine ( trivalent ) ( for adults ) specification: as per the who recommendations the trivalent vaccines for use in the 2023 influenza season ( sh ) contain the following: egg-based vaccines • an a / sydney / 5 / 2021 ( h1n1 ) pdm09-like virus; • an a / darwin / 9 / 2021 ( h3n2 ) -like virus; and • a b / austria / 1359417 / 2021 ( b / victoria lineage ) -like virus. whichever strain / s is / are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine ( trivalent ) ( for adults ) specification: as per the who recommendations the trivalent vaccines for use in the 2023 influenza season ( sh ) contain the following: egg-based vaccines • an a / sydney / 5 / 2021 ( h1n1 ) pdm09-like virus; • an a / darwin / 9 / 2021 ( h3n2 ) -like virus; and • a b / austria / 1359417 / 2021 ( b / victoria lineage ) -like virus. whichever strain / s is / are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine ( quadrivalent ) ( for adults ) specification: as per the who recommendations the quadrivalent vaccines for use in the 2023 influenza season ( sh ) contain the following: cell- or recombinant-based vaccines • an a / sydney / 5 / 2021 ( h1n1 ) pdm09-like virus; • an a / darwin / 6 / 2021 ( h3n2 ) -like virus; • a b / austria / 1359417 / 2021 ( b / victoria lineage ) -like virus; and • a b / phuket / 3073 / 2013 ( b / yamagata lineage ) -like virus. whichever strain / s is / are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine ( quadrivalent ) ( for adults ) specification: as per the who recommendations the quadrivalent vaccines for use in the 2023 influenza season ( sh ) contain the following: cell- or recombinant-based vaccines • an a / sydney / 5 / 2021 ( h1n1 ) pdm09-like virus; • an a / darwin / 6 / 2021 ( h3n2 ) -like virus; • a b / austria / 1359417 / 2021 ( b / victoria lineage ) -like virus; and • a b / phuket / 3073 / 2013 ( b / yamagata lineage ) -like virus. whichever strain / s is / are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine ( quadrivalent ) ( for adults ) specification: as per the who recommendations the quadrivalent vaccines for use in the 2023 influenza season ( sh ) contain the following: cell- or recombinant-based vaccines • an a / sydney / 5 / 2021 ( h1n1 ) pdm09-like virus; • an a / darwin / 6 / 2021 ( h3n2 ) -like virus; • a b / austria / 1359417 / 2021 ( b / victoria lineage ) -like virus; and • a b / phuket / 3073 / 2013 ( b / yamagata lineage ) -like virus. whichever strain / s is / are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine ( trivalent ) ( for adults ) specification: as per the who recommendations the trivalent vaccines for use in the 2023 influenza season ( sh ) contain the following: cell- or recombinant-based vaccines • an a / sydney / 5 / 2021 ( h1n1 ) pdm09-like virus; • an a / darwin / 6 / 2021 ( h3n2 ) -like virus; and • a b / austria / 1359417 / 2021 ( b / victoria lineage ) -like virus whichever strain / s is / are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine ( trivalent ) ( for adults ) specification: as per the who recommendations the trrivalent vaccines for use in the 2023 influenza season ( sh ) contain the following: cell- or recombinant-based vaccines • an a / sydney / 5 / 2021 ( h1n1 ) pdm09-like virus; • an a / darwin / 6 / 2021 ( h3n2 ) -like virus; and • a b / austria / 1359417 / 2021 ( b / victoria lineage ) -like virus whichever strain / s is / are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine ( trivalent ) ( for adults ) specification: as per the who recommendations the trrivalent vaccines for use in the 2023 influenza season ( sh ) contain the following: cell- or recombinant-based vaccines • an a / sydney / 5 / 2021 ( h1n1 ) pdm09-like virus; • an a / darwin / 6 / 2021 ( h3n2 ) -like virus; and • a b / austria / 1359417 / 2021 ( b / victoria lineage ) -like virus whichever strain / s is / are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months